vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and TRUPANION, INC. (TRUP). Click either name above to swap in a different company.
TRUPANION, INC. is the larger business by last-quarter revenue ($376.9M vs $359.9M, roughly 1.0× AdvanSix Inc.). On growth, TRUPANION, INC. posted the faster year-over-year revenue change (11.7% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $25.3M). Over the past eight quarters, TRUPANION, INC.'s revenue compounded faster (11.0% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
TRUPANION, INC.TRUPEarnings & Financial Report
Trupanion, Inc. is a pet insurance provider headquartered in Seattle, Washington. Established in 1998, Trupanion operates across the United States, Canada, Australia, and Puerto Rico. The company offers coverage for pets and is self-underwritten by the American Pet Insurance Company (APIC).
ASIX vs TRUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $376.9M |
| Net Profit | $-2.8M | — |
| Gross Margin | 7.6% | 17.3% |
| Operating Margin | -0.7% | 1.9% |
| Net Margin | -0.8% | — |
| Revenue YoY | 9.4% | 11.7% |
| Net Profit YoY | -892.9% | — |
| EPS (diluted) | $-0.11 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $376.9M | ||
| Q3 25 | $374.5M | $366.9M | ||
| Q2 25 | $410.0M | $353.6M | ||
| Q1 25 | $377.8M | $342.0M | ||
| Q4 24 | $329.1M | $337.3M | ||
| Q3 24 | $398.2M | $327.5M | ||
| Q2 24 | $453.5M | $314.8M | ||
| Q1 24 | $336.8M | $306.1M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $23.3M | — | ||
| Q4 24 | $352.0K | — | ||
| Q3 24 | $22.3M | — | ||
| Q2 24 | $38.9M | — | ||
| Q1 24 | $-17.4M | — |
| Q4 25 | 7.6% | 17.3% | ||
| Q3 25 | 6.8% | 16.4% | ||
| Q2 25 | 14.3% | 15.5% | ||
| Q1 25 | 14.2% | 14.9% | ||
| Q4 24 | 3.4% | 15.7% | ||
| Q3 24 | 14.4% | 15.1% | ||
| Q2 24 | 17.9% | 12.8% | ||
| Q1 24 | 0.9% | 11.8% |
| Q4 25 | -0.7% | 1.9% | ||
| Q3 25 | -0.9% | 1.6% | ||
| Q2 25 | 7.7% | 0.7% | ||
| Q1 25 | 7.7% | -0.4% | ||
| Q4 24 | -3.9% | 0.1% | ||
| Q3 24 | 7.5% | 0.5% | ||
| Q2 24 | 11.5% | -1.7% | ||
| Q1 24 | -7.0% | -2.0% |
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 6.2% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | -5.2% | — |
| Q4 25 | $-0.11 | $0.13 | ||
| Q3 25 | $-0.10 | $0.13 | ||
| Q2 25 | $1.15 | $0.22 | ||
| Q1 25 | $0.86 | $-0.03 | ||
| Q4 24 | $0.02 | $0.04 | ||
| Q3 24 | $0.82 | $0.03 | ||
| Q2 24 | $1.43 | $-0.14 | ||
| Q1 24 | $-0.65 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $370.7M |
| Total DebtLower is stronger | — | $101.8M |
| Stockholders' EquityBook value | $815.2M | $383.9M |
| Total Assets | $1.7B | $915.0M |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $370.7M | ||
| Q3 25 | $23.7M | $348.5M | ||
| Q2 25 | $18.4M | $319.6M | ||
| Q1 25 | $8.3M | $321.8M | ||
| Q4 24 | $19.6M | $307.4M | ||
| Q3 24 | $17.3M | $293.1M | ||
| Q2 24 | $12.1M | $277.2M | ||
| Q1 24 | $20.6M | $275.2M |
| Q4 25 | — | $101.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $127.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $383.9M | ||
| Q3 25 | $818.2M | $368.6M | ||
| Q2 25 | $823.7M | $355.5M | ||
| Q1 25 | $794.4M | $333.7M | ||
| Q4 24 | $774.6M | $323.3M | ||
| Q3 24 | $766.4M | $320.2M | ||
| Q2 24 | $746.6M | $305.8M | ||
| Q1 24 | $713.2M | $303.4M |
| Q4 25 | $1.7B | $915.0M | ||
| Q3 25 | $1.7B | $880.2M | ||
| Q2 25 | $1.6B | $847.8M | ||
| Q1 25 | $1.6B | $837.2M | ||
| Q4 24 | $1.6B | $806.9M | ||
| Q3 24 | $1.5B | $816.1M | ||
| Q2 24 | $1.5B | $795.9M | ||
| Q1 24 | $1.5B | $789.5M |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $29.3M |
| Free Cash FlowOCF − Capex | $36.1M | $25.3M |
| FCF MarginFCF / Revenue | 10.0% | 6.7% |
| Capex IntensityCapex / Revenue | 7.7% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $75.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $29.3M | ||
| Q3 25 | $26.6M | $29.2M | ||
| Q2 25 | $21.1M | $15.0M | ||
| Q1 25 | $11.4M | $16.0M | ||
| Q4 24 | $64.2M | $23.7M | ||
| Q3 24 | $57.3M | $15.3M | ||
| Q2 24 | $50.2M | $6.9M | ||
| Q1 24 | $-36.2M | $2.4M |
| Q4 25 | $36.1M | $25.3M | ||
| Q3 25 | $66.0K | $23.9M | ||
| Q2 25 | $-7.2M | $12.0M | ||
| Q1 25 | $-22.6M | $14.0M | ||
| Q4 24 | $29.8M | $21.8M | ||
| Q3 24 | $26.8M | $13.4M | ||
| Q2 24 | $16.7M | $4.0M | ||
| Q1 24 | $-71.6M | $-631.0K |
| Q4 25 | 10.0% | 6.7% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | -1.7% | 3.4% | ||
| Q1 25 | -6.0% | 4.1% | ||
| Q4 24 | 9.1% | 6.5% | ||
| Q3 24 | 6.7% | 4.1% | ||
| Q2 24 | 3.7% | 1.3% | ||
| Q1 24 | -21.3% | -0.2% |
| Q4 25 | 7.7% | 1.0% | ||
| Q3 25 | 7.1% | 1.4% | ||
| Q2 25 | 6.9% | 0.8% | ||
| Q1 25 | 9.0% | 0.6% | ||
| Q4 24 | 10.4% | 0.6% | ||
| Q3 24 | 7.7% | 0.6% | ||
| Q2 24 | 7.4% | 0.9% | ||
| Q1 24 | 10.5% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
TRUP
| Subscriptionbusiness | $261.4M | 69% |
| Other | $115.4M | 31% |
